Status:

UNKNOWN

Post-prandial Glycaemic Controlling Effects of BSG in Singapore Adults With Metabolic Syndrome

Lead Sponsor:

National University of Singapore

Collaborating Sponsors:

Ministry of Education, Singapore

Conditions:

Metabolic Syndrome

Diabetes

Eligibility:

All Genders

35-85 years

Phase:

NA

Brief Summary

The purpose of this study is to assess the glycaemic controlling effects of BSG and bio-transformed BSG-containing biscuits in Singapore adults with MetS. The investigators hypothesized that consumpti...

Detailed Description

This is a double-blind, randomised, crossover experiment. During the 3-week, 19 subjects will participate in a 3 meal tolerance test (MTT). During each MTT session, all subjects are required to consum...

Eligibility Criteria

Inclusion

  • Male and female participants, aged 35-85 years old
  • English-literate and able to give informed consent in English
  • Willing to follow the study procedures
  • Meet any 3 of the 5 following NCEP-ATP III MetS criteria: waist circumference \> 102 cm (male), \> 88 cm (female) (For Asian population: Waist circumference \> 90 cm (male), \> 80 cm (female)); fasting glucose concentration ≥ 100 mg/dL or on medication; triglyceride ≥ 150 mg/dL or on medication; high density lipoprotein cholesterol (HDL) \< 40 mg/dL (male), \< 50 mg/dL (female); systolic or diastolic blood pressure \> 130/85 mmHg or on medication);

Exclusion

  • Significant change in weight (≥ 3 kg body weight) during the past 3 months
  • Allergy to barley, wheat, corn, egg, or other ingredients found inside the biscuits.
  • Acute illness at the study baseline
  • Exercising vigorously\* over the past 3 months. \*Defined as having \> 6 metabolic equivalents of exercise daily; approximately 20 mins of moderate intensity exercise (e.g. slow jogging) a day
  • Following any restricted diet (e.g. vegetarian)
  • Smoking
  • Have a daily intake of more than 2 alcoholic drinks per day
  • Taking dietary supplements or food which may impact the outcome of interests (e.g. fermented foods, probiotic supplement etc.)
  • Consumption of antibiotics over past 3 months.
  • Pregnant, lactating, or planning pregnancy in the next 6 months
  • Insufficient venous access to allow the blood collection
  • Prescribed and taking antihypertensive/cholesterol-lowering/ type-2 diabetic medication which started less than 3 years prior to the intervention participation
  • High current intake of fibre\* from brown rice or wholemeal products. \*High, moderate or low intake taken as ≥ 6 servings, 4 - 5 servings, and ≤ 3 servings daily respectively based on My Healthy Plate guidelines
  • High current intake of fibre\* from vegetables. \* High, moderate or low intake taken as ≥ 2 servings, 2 servings, and ≤ 1 serving respectively based on My Healthy Plate guidelines

Key Trial Info

Start Date :

June 29 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2024

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT05421780

Start Date

June 29 2022

End Date

July 1 2024

Last Update

November 9 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yujing Xu

Singapore, Singapore, 117543